New Products

July 3rd 2025

Food Insecurity and the Dangers of Infant Formula Dilution

View our Q2 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.

January 30th 2023

Study: Idiopathic central precocious puberty patients at increased risk for psychiatric disorders

July 2nd 2025

Demystifying Infant Formula

Data from the study suggest caretakers of CPP patients be vigilant for psychiatric symptoms to begin care at an early stage.

October 11th 2022

FDA revises labeling on extended-release stimulants for ADHD to include weight loss risk

FDA news in pediatrics: June 2025

The revised labeling will warn that patients younger than 6 years taking these medications are at greater risk of weight loss.

Q2 2025: A recap of the top headlines and interviews

A look back at the FDA submissions and regulatory decisions in the pediatric health care space from June 2025.

Related Content

July 3rd 2025

Food Insecurity and the Dangers of Infant Formula Dilution

View our Q2 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.

January 30th 2023

Study: Idiopathic central precocious puberty patients at increased risk for psychiatric disorders

July 2nd 2025

Demystifying Infant Formula

Data from the study suggest caretakers of CPP patients be vigilant for psychiatric symptoms to begin care at an early stage.

October 11th 2022

FDA revises labeling on extended-release stimulants for ADHD to include weight loss risk

FDA news in pediatrics: June 2025

The revised labeling will warn that patients younger than 6 years taking these medications are at greater risk of weight loss.